Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Oscar B. Lahoud"'
Autor:
Anthony R. Mato, Doris M. Ponce, Esperanza B. Papadopoulos, Oscar B Lahoud, Lindsey E. Roeker, Andrew D. Zelenetz, Sean M. Devlin, Juliet N. Barker, Boglarka Gyurkocza, Parastoo B. Dahi, James W. Young, Guenther Koehne, Sergio Giralt, Molly Maloy, Craig S. Sauter, Ann A. Jakubowski, Miguel Perales, Hugo Castro-Malaspina
Publikováno v:
Blood Adv
Allogeneic hematopoietic stem cell transplantation (HSCT) may potentially cure patients with chronic lymphocytic leukemia (CLL) and Richter’s transformation (CLL-RT) or CLL without RT, but the impact of novel agents on HSCT is unclear. CLL-RT patie
Autor:
Heather Landau, Alexandra Gomez-Arteaga, Eric L. Smith, Raymond E. Baser, Sergio Giralt, Arnab K. Ghosh, David J. Chung, Michael Scordo, Parastoo B. Dahi, Oscar B Lahoud, Miguel-Angel Perales, Guenther Koehne, Adam Bryant, Gunjan L. Shah, Brian C. Shaffer, Josel D. Ruiz, Ola Landgren
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:2040-2046
Allogeneic hematopoietic cell transplantation (alloHCT) for multiple myeloma (MM), with its underlying graft-versus-tumor capacity, is a potentially curative approach for high-risk patients. Relapse is the main cause of treatment failure, but predict
Autor:
Hillard M. Lazarus, Minoo Battiwalla, Jean A. Yared, Baldeep Wirk, Robert Peter Gale, Ibrahim Ahmed, Marcelo C. Pasquini, Sachiko Seo, Bipin N. Savani, Leona Holmberg, Richard T. Maziarz, Gerhard C. Hildebrandt, Richard F. Olsson, Nelli Bejanyan, Shahinaz M. Gadalla, Mingwei Fei, Kehinde Adekola, Mahmoud Aljurf, Oscar B Lahoud, Jeffrey Auletta, Seth J. Rotz, Vaibhav Agrawal, Claudio G. Brunstein, Jan Cerny, Soyoung Kim, Shin Mineishi, Vikram Mathews, Harry C. Schouten, Siddhartha Ganguly, Cesar O. Freytes, Miguel-Angel Perales, Joseph S. Bubalo, Peiman Hematti, Maxim Norkin, Ran Reshef, Marcos de Lima, Taiga Nishihori, Stefan O. Ciurea, John Rogosheske, Heather Landau, Lynette Chee, Shahrukh K. Hashmi
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol 25, iss 3
Biology of Blood and Marrow Transplantation, 25(3), 480-487. Elsevier Science
Biology of Blood and Marrow Transplantation, 25(3), 480-487. Elsevier Science
Data are limited on whether to adjust high-dose chemotherapy before autologous hematopoietic cell transplant (autoHCT) in obese patients. This study explores the effects of dose adjustment on the outcomes of obese patients, defined as body mass index
Autor:
Michael Scordo, Lakshmi V. Ramanathan, Heather Landau, Kazunori Murata, Eric L. Smith, Sean M. Devlin, Sydney X. Lu, Hani Hassoun, Urvi A Shah, Gunjan L. Shah, Ola Landgren, Caleb Ho, Neha Korde, Benjamin Diamond, Ahmet Dogan, Sham Mailankody, Carlyn Tan, Oscar B Lahoud, Kylee H Maclachlan, Tim J Peterson, Maria E. Arcila, David J. Chung, Andriy Derkach, Katie L. Thoren, Francesco Maura, Alexander M. Lesokhin, Even H Rustad, Sergio Giralt, Mikhail Roshal, Malin Hultcrantz
Publikováno v:
The Lancet. Haematology. 8(6)
Background Lenalidomide maintenance improves progression-free survival for patients with multiple myeloma, although its optimal duration is unknown. Clearance of minimal residual disease (MRD) in the bone marrow results in superior outcomes, although
Autor:
Venkata Yellapantula, Eileen M Boyle, Sydney Lu, Ahmet Dogan, Heather Landau, Jonathan U. Peled, Marc A. Attiyeh, Yanming Zhang, Gareth J. Morgan, Michael Scordo, Malin Hultcrantz, Alvin Makohon-Moore, Urvi A Shah, Gary A. Ulaner, Oscar B Lahoud, Francesco Maura, Juan S. Medina-Martinez, Even H Rustad, Yangyu Zhou, Cody Ashby, Eric Alden Smith, Gunes Gundem, David J. Chung, Rajya Kappagantula, Max Levine, Kylee H Maclachlan, Priscilla Baez, Juan E. Arango Ossa, Ola Landgren, Elli Papaemmanuil, Patrick Blaney, Hani Hassoun, Frits van Rhee, Gunjan L. Shah, Minal Patel, Benjamin Diamond, Lance Zhang, Alexander M. Lesokhin, Sergio Giralt, Christine A. Iacobuzio-Donahue, Sham Mailankody, Neha Korde
Publikováno v:
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
Multiple myeloma (MM) progression is characterized by the seeding of cancer cells in different anatomic sites. To characterize this evolutionary process, we interrogated, by whole genome sequencing, 25 samples collected at autopsy from 4 patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bda033ec341c7bf7cf17269cc22bcdf
Publikováno v:
Leuk Lymphoma
Multiple myeloma (MM) is a plasma cell neoplasm that affects elderly individuals with two-thirds of patients over 65 years at diagnosis. However, data available are derived from clinical trials conducted in younger patients. Fewer studies investigate
Publikováno v:
Bone Marrow Transplantation. 53:654-656
Autor:
Sergio Giralt, Ahmet Dogan, C. Ola Landgren, Oscar B Lahoud, David J. Chung, Nikoletta Lendvai, Hani Hassoun, Heather Landau, Sean M. Devlin
Publikováno v:
Biol Blood Marrow Transplant
Treatment for AL amyloidosis aims to eradicate clonal plasma cells, thereby disrupting the amyloid deposition causing organ damage. Risk-adapted high-dose melphalan plus autologous stem cell transplantation (RA-ASCT) is an effective therapy. We condu
Autor:
Neha Korde, Sean M. Devlin, Eric L. Smith, Hani Hassoun, Alexander M. Lesokhin, Oscar B Lahoud, Nikoletta Lendvai, Ola Landgren, Malin Hultcrantz, Sham Mailankody, Meghan Salcedo, Elizabet Tavitian
Publikováno v:
Journal of Clinical Oncology. 37:8051-8051
8051 Background: Patients with high risk smoldering multiple myeloma (HR-SMM) have an increased risk of progression to multiple myeloma (MM)- median time < 2 years. The standard management of these patients currently is close clinical monitoring; how
Autor:
Ahmet Dogan, Carlos Fernández de Larrea, Oscar B Lahoud, Neha Korde, Kevin J. Curran, Brigitte Senechal, Craig S. Sauter, Nikoletta Lendvai, Pallavi Khattar, Achim A. Jungbluth, Analisa Wills, Mikhail Roshal, Ola Landgren, David J. Chung, Malin Hultcrantz, Maria Lia Palomba, Qi Gao, Claudia Diamonte, Renier J. Brentjens, Michael Scordo, Alexander M. Lesokhin, John Pineda, Sham Mailankody, Terence J. Purdon, Hani Hassoun, Sergio Giralt, Elizabeth Halton, Isabelle Riviere, Gunjan L. Shah, Xiuyan Wang, Jae H. Park, Pavan Anant, Arnab Ghosh, Heather Landau, Eric L. Smith, Mette Staehr, Yvette Bernal
Publikováno v:
Blood. 132:959-959
Introduction: BCMA targeted CAR T cell therapy has shown promising results in patients with relapsed/refractory multiple myeloma (MM). Herein, we report on the safety and efficacy of MCARH171, a second generation, human derived BCMA targeted autologo